BENIGN PROSTATIC HYPERPLASIA AND CANCER OF PROSTATE

被引：0
|
作者：
BYAR, DP [1 ]
机构：
[1] NCI,CLIN & DIAG TRIALS SECT,BETHESDA,MD 20014
来源：
LANCET | 1975年 / 1卷 / 7911期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：866 / 866
页数：1
相关论文
共 50 条
  • [41] Progesterone receptor in the prostate: A potential suppressor for benign prostatic hyperplasia and prostate cancer
    Chen, RuiQi
    Yu, Yue
    Dong, Xuesen
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017, 166 : 91 - 96
  • [42] Estrogen receptors in the human male prostatic urethra and prostate in prostatic cancer and benign prostatic hyperplasia
    Bodker, A
    Bruun, J
    Balslev, E
    Iversen, HG
    Meyhoff, HH
    Andersson, KE
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1999, 33 (04): : 237 - 242
  • [43] Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases
    Brössner, C
    Petritsch, K
    Fink, K
    Auprich, M
    Madersbacher, S
    Adlercreutz, H
    Rehak, P
    Petritsch, P
    [J]. UROLOGY, 2004, 64 (04) : 707 - 711
  • [44] METACHROMASIA IN THE PROSTATE - A HISTOCHEMICAL DIFFERENCE BETWEEN BENIGN PROSTATIC HYPERPLASIA AND PROSTATIC-CANCER
    ARCADI, JA
    [J]. JOURNAL OF UROLOGY, 1987, 137 (04): : A370 - A370
  • [45] BENIGN PROSTATIC HYPERPLASIA, PROSTATIC CANCER, AND CARCINOGENESIS
    ROTKIN, ID
    [J]. LANCET, 1975, 2 (7930): : 359 - 360
  • [46] Statins and the Risk of Prostate Cancer or Benign Prostatic Hyperplasia: Biological Plausibility
    Getzenberg, Robert H.
    [J]. JOURNAL OF UROLOGY, 2010, 184 (02): : 415 - 416
  • [47] Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
    S-C Hung
    S-W Lai
    P-Y Tsai
    P-C Chen
    H-C Wu
    W-H Lin
    F-C Sung
    [J]. British Journal of Cancer, 2013, 108 : 1778 - 1783
  • [48] New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia
    De Marzo, AM
    Coffey, DS
    Nelson, WG
    [J]. UROLOGY, 1999, 53 (03) : 29 - 40
  • [49] Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia
    Matos, A. R.
    Coutinho-Camillo, C. M.
    Thuler, L. C. S.
    Fonseca, F. P.
    Soares, F. A.
    Silva, E. A.
    Gimba, E. R.
    [J]. EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 94 (03) : 438 - 444
  • [50] AUA San Diego 2013: benign prostatic hyperplasia, prostate cancer
    Masson-Lecomte, A.
    [J]. PROGRES EN UROLOGIE, 2013, 23 : F94 - F97
12345